Analytics
The AI-backed genomic and clinical data company announced it had laid off about 250 workers in August.
Its technology helps eliminate manual steps in reporting and interpretation of ultrasound images of breast and thyroid.
Its AI mammography solution will support screening exams for 350,000 women annually.
Sonde is its second global digital health investment to date.
Also, Global Health is deploying its patient engagement and data solutions to the upcoming George Centre.
Also, Smith+Nephew has launched a digital innovation centre in Singapore.
It can diagnose diabetic retinopathy and diabetic macular oedema in 5-10 seconds.
NeuTrace focused on developing in-procedure AI tools for electrophysiology.
It will use IRIS for Health to facilitate its entry into the global hospital market.
Also, Syntekabio has launched its cloud service platform for AI drug discovery.